Psoriasis

Psoriasis | Unmet Need | US/EU | 2016

 

Affecting more than 3 million people in the major pharmaceutical markets, moderate to severe psoriasis represents a large market with substantial commercial potential. Significant opportunities…

Psoriasis | Pharmacor | G7 | 2015

Last Updated 23 December 2015
The psoriasis market has become increasingly lucrative owing to the growing use of biologics. The dominance of the tumor necrosis factor-alpha (TNF-α) inhibitors is…

Psoriasis | TreatmentTrends | US | 2015

The TreatmentTrends: Psoriasis 2015 (US) report explores treatment dynamics and their evolution among 100 U.S. dermatologists, through comprehensive primary research methods. The use of biologic…

Psoriasis | Chart Trends | US | 2014

ChartTrends®: Psoriasis 2014 (US) provides insight into the management and treatment of psoriasis patients by dermatologists based on actual patient-level data. More than 180 U.S. dermatologists…